Physical functioning

In the table below, entries in the left column refer to the related documentation, while the values in the cells of columns LASA-B to LASA-J refer to the corresponding LASA-data files (e.g. ‘161‘ in column B refers to: ‘LASAB161‘). Table entries are hyperlinks. Hovering  over the waves in the header will show the years in which the corresponding measurements took place.

In case entries are preceeded by ‘o’, the corresponding files are related to the OSTEOPOR-dataset (e.g. o80 refers to ‘LASAo80′). Likewise, prefixes ‘g’, ‘z’, ‘zo(a)’, ‘zh’, ‘ch’, and ‘zd’ refer to other special datasets, more information will follow.

UC: Under Construction.

For more details about the LASA-waves, see Design LASA.

Note that some of the data are not yet available (in red).

LASA-WAVE BCDE2BFGH3BMBIJK 
Cohort 1
Cohort 2
Cohort 3
Migrant Cohort
THEME PHYSICAL
Blood pressureBCDE2BFGH3BMBIJK
Blood pressure/pulse
– retests
151
151
151
151
151
151
151
151
151
151
151
151
151
151
151
151
151
151
151
151
Body compositionBCDE2BFGH3BMBIJK
Anthropometry

– Weight and height

– Calf measurement

– Ankle, Knee and Pulse width

161

161

171

161

161



185
161

161

171

161

161

171

161

161

171

161

161

171

161

161

171

161

161

171

161

161

171

161

161




161

161

161


161

161

161


161

161

161


Weight and height:
history and weight changeIM

– tel. respondent*

160


160


160


160


160


160


160


160


160


160


160


714

160


714
160


714
Bio-electrical impedance
(subsample)
**
172 –
Birth weight
134134134 –
Perceived body shape
– scaled
**





145
345
145
345


145
345
145



DXA (LASA ancillary study)
– Hip / lumbar spine scan
– Whole body scan

o41
o42
o41
o42










Chronic diseasesBCDE2BFGH3BMBIJK
Self-report of chronic diseasesIM
– nr. of diseases reported

– tel. proxy*
– tel. respondent*

– longitudinally cleaned

035
235





435
035
235


602
702

435
035
235


602
702


035
235


602
702


035
235





035
235


602
702


035
235


602
702


035
235


602
702


035
235





035
235





035
235


602
702


035
235


602
702


035
235

602
702

GP informationg01g01g01g01UCg01g01
Aortic calcification
(lateral radiographs)

zo22zo22
Diabetes mellitus
(algorithm)

zdc1zdc1zdc1zdc1zdc2zdc1
zdc2
zdc1
zdc2
zdc1
zdc2


zdc3
zdc1
zdc2
zdc3
UCUC
Rheumatoid Arthritis
(algorithm)

UC
Osteoarthritis hip
and knee
(algorithm)

zoa1
zoa1zoa1 zoa1zoa2zoa1
zoa2
zoa1
zoa2
zoa1
zoa2


zoa3
zoa1
zoa2
zoa3
UCUC
Metabolic syndrome
ch02
Allostatic Load (algorithm)
X
Cardiovascular diseases
(algorithm)

zh01zh01zh01
Parkinson: early P. related signs**
096096
Decubitus
(bedsores)

116
159












Hyperthyroidism**
182 182
Back pain182
182
182
Bedridden
182182
182
182
182
182
FertilityBCDE2BFGH3BMBIJK
Fertility (women)
119 1811 181 181
181
FallingBCDE2BFGH3BMBIJK
Falls

– tel. proxy*
– tel. respondent*

– Falls last year








605
705

187


605
705

187






























187





187










187





187
Falls: circumstances and
consequences

187
187187
Falls: environmental
conditions (home)
**
180
180
Falls: fear of falling
(FES: Falls Efficacy Scale)

183
183
Falls: prevention of fall
accidents (LASA ancillary study)

X
Falls: 3y prospective fall
calendar (LASA ancillary study)
X
Falls: 1y prospective fall
calendar (LASA ancillary study)

X
DizzinessIM
187
187
187
187
187
187
187
187
187187
Adjustments and walking aids**
187187187187187187187 –
Foot problems
185185185185– 
FracturesBCDE2BFGH3BMBIJK
Fractures
– total waves B-F
– per wave

– tel. proxy*
– tel. respondent*
zo13



zo13
186

605
705
zo13
186

605
705
zo13
186

605
705
zo13
186


zo13
186

605
705
186

605
705
186

605
705
186


186


186

605
705
186

605
705
186

605
705
Vertebral deformities
zo22zo22
Quantitative ultrasound of bone
o31o31
Frailty
BCDE2BFGH3BMBIJK
Various definitions (e.g., frailty
phenotype, frailty index)

XX  X  X  X  X   X  XXXXX
LifestyleBCDE2BFGH3BMBIJK
Alcohol useIM
– scaled
153
353
153
353
153
353
153
353
153
353
153
353
153
353
153
353
153
353
153
353
153
353
153
353
153
353
Diet and food consumption


Lifestyle study
(LASA ancillary study)


Nutrition and food-related
behaviour (LASA ancillary study)

with subtopics:
– Eating patterns
– Weight(loss) and appetite
– Mindful eating
– Meals and snack
– Interoceptive awareness
of hunger and satiety
– Alexithymia
– Binge eating
– Eating styles
– Problems food intake
– Use of amenities
– Food products for older adults
– Dietary recommendations
– Sustainable behaviour
– Change in sleep and appetite
118


118
184

118
184










X



118








118


118


118


MicMac study
(LASA ancillary study)

X
Oral health
X2126126126
Physical activityIM
046
046
046
046 046 046 046 046 046 046 046 046 046
Daily Physical Activity** 162
Early life physical activity246
Perceived physical activity (LIVAS)
– scaled
114
314
114
314
114
314
114
314
114
314
114
314







Accelerometry
(LASA ancillary studies)
– subsample (St. 1)
– subsample (St. 2)
– subsample (St. 3)
– subsample (St. 4)

































X2





X






X3


















X
 











Sedentary behavior
– scaled
– scaled













101
301
501
101
301
501
101
301
501
101
301
501
101
301
501
101
301
501
101
301
501
SmokingIM
154 154 154 154 154 154 154 154 154 154 154 154 154
Medication/
supplements
BCDE2BFGH3BMBIJK
Medication and
food supplement use4
– types of medication

152

352
152

352
152

352
152

352
152

352
152

352
152

352
152

352
152

352
152

352
152

352
152

352
152

352
Food supplement use4
– Vitamin D use included










174
374
174
374
174
374
PainBCDE2BFGH3BMBIJK
Subjective painIM
– scaled

115
315

115
315

115
315

115
315

115
315

115
315

115
315

115
315

115
315

115
315

115
315

 115
315

115
315

Dealing with pain**
188
 –
Pain drawing
188
 –
Perception: VisionBCDE2BFGH3BMBIJK
Vision (self-report)IM
– total scores

– tel. proxy*
– tel. respondent*

031
231




031
231


604
704
031
231


604
704
031
231


604
704
031
231




031
231


604
704
031
231


604
704
031
231


604
704
031
231




031




031
231


604
704
031
231


604
704
031
231

604
704
Visual acuity test
– Vision-related quality of life




191
192


191
192
191
192
191
192
191




Vision: contrast sensitivity
157157157157157157
Perception: HearingBCDE2BFGH3BMBIJK
Hearing (self-report)IM
– total scores

– tel. proxy*
– tel. respondent*

031
231




031
231


604
704
031
231


604
704
031
231


604
704
031
231




031
231


604
704
031
231


604
704
031
231


604
704
031
231




031




031
231


604
704
031
231


604
704
031
231

604
704
Hearing: Speech
in Noise Test (SNT)
Hearing: SNT questions






193

194


193

194
193

194






193

194




Perception: smellBCDE2BFGH3BMBIJK
Olfactory function
S00
S01
S02
S00
S01
S02
Physical functioningBCDE2BFGH3BMBIJK
Funct. limitations (ADL)IM
– constructed

– tel. proxy*
– tel. respondent*


Use of assistive
devices or assistance


Limitations in joint mobility

Funct. limitations partner (ADL)
030
230





030




030
230


603
703

030


183

030
230


603
703

030


183

030
230


603
703

030


183

139
030
230





030




030
230


603
703

030




139
030
230


603
703

030




139
030
230


603
703

030




139
030
230





030




139
030
230





030




030
230


603
703

030




139
030
230


603
703

030




139
030
230

603
703

030





139
Global Activity Limitations
– tel. respondent*
033
033
703
033
703
033
703
033
033
703
033
703
033
703
033

033
703
033
703
033
703
Physical performance
034034034034034034034034034034034034034
Pulmonary function test
– Peak Flow
– Spirometry
(post bronchodilator)

158

158

158

158



158

158



168








Grip strength
161161161161161161161161161161161161
Quality of life
BCDE2BFGH3BMBIJK
EuroQol
– scaled




135
335

135
335
135
335
135
335
135
335

135
335


Qualeffo-41
– (non)response
– Qualeffo scores
– total scores







o80
o81
o82


















SF-12 Health Survey
– scaled
– scaled (Am.)





133
333
533
133
333
533


133
333
533
133
333
533
133
333
533
133
333
533


133
333
533
133
333
533
133
333
533
WHO Quality of Life**
133
133133
Self-rated health
– GHPQ
– GHPQ: scaled

– tel. proxy*
– tel. respondent*

036
113
313



036
113
313


602
702
036
113
313


602
702
036
113
313


602
702
036
113
313



036
113
313


602
702
036
113
313


602
702
036
113
313


602
702
036
113
313



036




036



602
702
036



602
702
036



602
702
LASA-wave BCDE2BFGH3BMBIJK

* Files in the 700 series contain data from telephone interviews held with respondents, while files in the 600 series contain data from telephone interviews held with proxies. In wave C however, the same questionnaire was used for both respondent and proxy; data was stored in the 600 series.

** Not yet documented

1 Fertility (Women) moved from self-administered questionnaire (LASAB119) to medical interview (LASAC181 / LAS2B181 / LAS3B181 / LASMB181)
2 As part of the Lifestyle study
3 As part of the EPOSA study
4 In wave I Food supplement questions moved to LASA174
IM In 2004, three years after wave E an interim measurement was carried out on the first cohort, see the specific topics for more details. More information will follow.